Frequently Asked Questions

What is the Practice to Policy® Health Awards Programme?

The Practice to Policy® Health Awards Programme was launched to support innovative solutions in primary biliary cholangitis (PBC), with two parallel programmes for the United States and for Europe and Canada. The programme will provide financial support for short-term initiatives that are funded for up to one year.

In 2019, Intercept will support six to eight new innovative projects with up to €25,000 (or local currency equivalent) per project. In addition to this, and new in 2019, Intercept will provide up to three awards to projects which replicate previous Practice to Policy® winners (up to €15,000 per project).

Is my project eligible for a Practice to Policy® award?

The Practice to Policy® Health Awards Programme in PBC encourages the development of innovative projects, which are designed to improve the lives of people living with PBC. In 2019, we are focusing on local and national projects that pioneer collaborative care between healthcare professionals and people living with PBC. Specifically, we are seeking projects that:

  • Create tools or platforms that enable or encourage timely monitoring of patients
  • Provide resources to improve the dialogue between people living with PBC and their healthcare professional 
  • Encourage collaborative care in PBC, e.g. through the appropriate use of existing or emerging best practice guidelines

Projects that are not eligible

Patient apps: Please note, we will not be accepting project applications which focus on the development of patient apps. The Practice to Policy® programme is supporting a separate patient app initiative to ensure that our efforts as a community can be combined. If you would be interesting in becoming involved in this, please get in touch with the team at practicetopolicy@interceptpharma.com.

Recurring projects: While we will be supporting applications which seek to replicate winning projects, we will not be accepting applications for recurring projects from previous winners themselves. Ongoing projects are still eligible to apply; however, applications must act as standalone and distinct components of the organisation or institution’s activities, and clearly align to the 2019 eligibility criteria.

What is the difference between a recurring and replicated project?

Replicated projects are projects which replicate a previous Practice to Policy® award winner’s project. Recurring projects are projects from previous winners who wish to repeat a project which has already been funded.

Are replicated project applications different to projects submitted to the main awards programme?

Applications which seek to replicate a previous Practice to Policy® project will be judged separately to those submitted as part of the main programme. Whilst most of the judging criteria will apply, replicated projects will not have to demonstrate the following:

  • Innovation in PBC
  • The ability to generate insights, evidence and learning for the wider healthcare community

Do replicated projects have to align with the 2019 eligibility criteria: Collaborative Care?

Applications should as much as possible align with the 2019 topic criteria. However, this will not have as heavy a weighting as with projects submitted for the main awards programme, as the projects to be replicated are winners from previous application cycles who had different eligibility criteria.

Do all the same guidance and rules apply with replicated projects?

As with the main awards, you should ensure you have read and understood the application guide in full before submitting your application. All the same rules and guidance applies for applications seeking funding for replicated projects, unless otherwise stated in the document.

Who can apply for an award?

The Practice to Policy® Health Awards Programme will consider applications from:

  • Healthcare organisations
  • Academic institutions
  • Policy organisations
  • Patient organisations

Which types of projects are not covered by Practice to Policy® funds?

The Practice to Policy® Health Awards Programme will not cover grants for:

  • Investigator-initiated grants
  • Medical education grants
  • Core funding grants

Which countries are eligible for the Practice to Policy® Europe and Canada Programme?

In addition to countries within Europe and Canada, the programme is open to any country outside of the U.S. Whilst the programme topics and projects may largely focus on Europe and Canada, we welcome innovation and best practice learnings from across the world.

For further information, please email the Practice to Policy® team at practicetopolicy@interceptpharma.com.

How long does the application window stay open?

The application window for the Practice to Policy® PBC Programme in Europe and Canada closes on 8 September 2019.

How can eligible projects apply?

Applicants can apply for an award by downloading an application form, which can be found by selecting “Apply” under the PBC Awards tab on the Practice to Policy® website. Once you have completed the form, please submit via email at practicetopolicy@interceptpharma.com, along with the required supporting documentation.

When will applicants learn the outcome?

The Practice to Policy® Health Awards Programme will let applicants know the outcome of their application by January 2020.

Are research projects eligible to apply?

Research projects are not eligible to apply. If you are seeking grants or other funding for medical education (either CME or IME), please send your enquiries to grants@interceptpharma.com. If you are interested in Investigator-Initiated Research grants, please send your enquiries to IIR@interceptpharma.com.

Can applicants apply two years in a row?

The Practice to Policy® Health Awards Programme can only provide funding for projects of up to one year, we will not be accepting applications for recurring projects from previous winners themselves.

It is possible to apply for support for an ongoing project. However, the project for which the applicant is requesting funding must act as a standalone and distinct component of the organisation or institution’s activities, and clearly align to the 2019 eligibility criteria. As part of the funding conditions, Intercept would require the methodology, results, and learnings of the funded project to be disseminated through relevant channels; the existence of ongoing components of a project must not compromise the ability to communicate best practices developed through the Intercept award.

It is also possible to apply for support for projects which replicate a previous Practice to Policy® award winner’s project.

Does all project funding need to come from the Practice to Policy® award?

Applicants can apply whether or not they have additional sources of funding. However, there must be an appropriate project deliverable associated with the Practice to Policy® one-year funding timeline.

What commitments would successful applicants have to make?

Successful applicants will be required to:

  • Conduct a final review of the project, including allocation of funding and plans for publication
  • Permit the sharing of their organisation/institution details in addition to their funded project being highlighted on the Intercept Europe and Canada Practice to Policy® Health Awards Programme website
  • Commit to the dissemination of their methodologies and results through relevant channels, including but not limited to: publications, manuscripts, and toolkits to ensure education around best practices within and beyond their organisation/institution’s network. Intellectual property rights would remain in the ownership of the project leads. It is Intercept’s policy in line with transparent disclosure requirements, that any publication acknowledges financial support from Intercept

Does the Practice to Policy® Health Awards Programme cover capital expenditure?

The programme does not cover capital expenditure, e.g. funding for purchasing equipment will not be provided; however, lease costs for the duration of the project are possible.

Does funding cover time for existing staff?

Funding does not cover time for existing permanent staff. Only temporary staff costs directly related to the project will be funded.

What funding is not eligible?

Please note that Intercept is unable to offer funding for:

  • Patient apps
  • Entertainment
  • Recurring projects, i.e. a project which has received an award previously, and is requesting repeat funding
  • Activities that are not fundamental to the delivery of the project; e.g. funding which supports an organisation’s day-to-day work
  • Costs associated with capital expenditure, e.g. funding for purchasing equipment will not be provided; however, lease costs for the duration of the project are possible
  • Permanent staff costs: Only temporary staff costs directly related to the project can be funded
  • The following grants:
    • Investigator-initiated research grants (IIRs): If you are interested in an investigator- initiated research grant, please visit: https://research.interceptpharma.com.
    • Medical education grants: If you are seeking grants or other funding for medical education (either CME or IME), please visit: https://grants.interceptpharma.com.
    • Core funding grants: This type of funding supports an organisation’s day-to-day work and may go towards the costs of the organisation’s administration, e.g. staff costs, office rental, stationery costs, etc. and/or core initiatives. If you are seeking patient group core funding grants, please email: internationalgrants@interceptpharma.com.